Celldex Therapeutics, Inc.s Most Important Takeaway From Q3 Isnt a Number - Yahoo Canada Shine On
Slightly above 67% of Celldex Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Celldex Therapeutics stock suggests that many investors are alarmed at this time. Celldex Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Celldex Therapeutics' earnings reports, geopolitical events, and overall market trends.
Celldex |
Celldex Therapeutics, Inc.s Most Important Takeaway From Q3 Isnt a Number Yahoo Canada Shine On
Read at news.google.com
 |
Celldex Therapeutics Fundamental Analysis
We analyze Celldex Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celldex Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celldex Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Celldex Therapeutics is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Celldex Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Celldex Therapeutics stock to make a market-neutral strategy. Peer analysis of Celldex Therapeutics could also be used in its relative valuation, which is a method of valuing Celldex Therapeutics by comparing valuation metrics with similar companies.
Peers
Celldex Therapeutics Related Equities
| DAWN | Day One | 11.31 | ||||
| DYN | Dyne Therapeutics | 4.28 | ||||
| BCAB | Bioatla | 2.56 | ||||
| RVMD | Revolution Medicines | 1.67 | ||||
| CERE | Cerevel Therapeutics | 0.92 | ||||
| KROS | Keros Therapeutics | 0.16 | ||||
| IDYA | Ideaya Biosciences | 0.77 | ||||
| CRNX | Crinetics Pharmaceuticals | 0.94 | ||||
| SWTX | SpringWorks Therapeutics | 1.25 | ||||
| CYTK | Cytokinetics | 1.59 | ||||
| ANAB | AnaptysBio | 2.10 | ||||
| MGTX | MeiraGTx Holdings | 2.73 | ||||
| TVTX | Travere Therapeutics | 3.14 | ||||
| RNA | Avidity Biosciences | 3.21 | ||||
| IMTX | Immatics | 3.31 | ||||
| COGT | Cogent Biosciences | 3.41 | ||||
| VTYX | Ventyx Biosciences | 4.51 | ||||
| ALXO | Alx Oncology | 6.10 | ||||
| EWTX | Edgewise Therapeutics | 6.85 | ||||
| AVTE | Aerovate Therapeutics | 14.55 |
Additional Tools for Celldex Stock Analysis
When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.